Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Cardiac Assist Devices are used to support the failing heart when it cannot be managed with standard medical therapy. Cardiopulmonary Bypass Equipment temporarily takes over the function of the heart and lungs during open-heart surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardiopulmonary bypass equipment devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the cardiopulmonary bypass equipment market in the UK was LivaNova followed by Terumo, Medtronic, Getinge, Braile Biomedica, Abiomed and Technowood.
Cardiopulmonary Bypass Equipment is also known as a heart-lung machine. The equipment is used to divert blood returning to the heart, before it returns to the arterial circulation. It works both as a heart i.e., pumps blood and as lungs i.e., supply oxygenated blood to the RBCs.
The value of the cardiopulmonary bypass equipment devices market within the UK was expected to be over $30m in 2023.
For the latest complete market share analysis of cardiopulmonary bypass equipment device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
